Zimmer Biomet Holdings (ZBH) Non-Current Deferred Tax Liability (2011 - 2026)
Zimmer Biomet Holdings (ZBH) posted quarterly Non-Current Deferred Tax Liability of $249.9 million for Q1 2026, up 2.38% quarter-over-quarter from $244.1 million in Q4 2025.
Zimmer Biomet Holdings (ZBH) Non-Current Deferred Tax Liability (2011 - 2026) Analysis & Trends
Zimmer Biomet Holdings' Non-Current Deferred Tax Liability history runs 15 years deep, the most recent figure standing at $249.9 million for Q1 2026.
- In Q1 2026, Non-Current Deferred Tax Liability changed N/A year-over-year to $249.9 million; the TTM figure through Mar 2026 stood at $249.9 million (changed N/A YoY), while the FY2025 annual figure was $244.1 million, down 30.75% from the prior year.
- Non-Current Deferred Tax Liability for Q1 2026 stood at $249.9 million, up from $244.1 million in the prior quarter.
- The five-year high for Non-Current Deferred Tax Liability was $541.3 million in Q3 2022, with the low at $244.1 million in Q4 2025.
- The 5-year median for Non-Current Deferred Tax Liability is $470.1 million (2022), against an average of $419.3 million.
- The sharpest annual moves came in 2022 and 2023: Non-Current Deferred Tax Liability slumped 35.99% in 2022, then fell 1.12% in 2023.
- Zimmer Biomet Holdings' Non-Current Deferred Tax Liability stood at $474.8 million in 2022, then fell by 24.68% to $357.6 million in 2023, then slipped by 1.43% to $352.5 million in 2024, then sank by 30.75% to $244.1 million in 2025, then advanced by 2.38% to $249.9 million in 2026.
- Business Quant data shows ZBH's Non-Current Deferred Tax Liability at $249.9 million in Q1 2026, $244.1 million in Q4 2025, and $352.5 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.21 Bn | 18.80 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 235.60 Mn |
| Jun 30, 2026 | 235.60 Mn |
| Mar 31, 2026 | 249.90 Mn |
| Mar 31, 2026 | 249.90 Mn |
| Dec 31, 2025 | 244.10 Mn |
| Dec 31, 2025 | 244.10 Mn |
| Dec 31, 2024 | 352.50 Mn |
| Dec 31, 2024 | 352.50 Mn |
| Mar 31, 2024 | 370.40 Mn |
| Mar 31, 2024 | 370.40 Mn |
| Dec 31, 2023 | 357.60 Mn |
| Dec 31, 2023 | 357.60 Mn |
| Sep 30, 2023 | 465.40 Mn |
| Sep 30, 2023 | 465.40 Mn |
| Jun 30, 2023 | 474.90 Mn |
| Jun 30, 2023 | 474.90 Mn |
| Mar 31, 2023 | 484.60 Mn |
| Mar 31, 2023 | 484.60 Mn |
| Dec 31, 2022 | 474.80 Mn |
| Dec 31, 2022 | 474.80 Mn |